Parker Waichman LLP

Diabetes Trial Deaths End Part of Study

A diabetes drug trial was halted recently after it was determined that trial participants receiving aggressive diabetes treatment were dying at a higher rate than those who did not receive intensive therapy.  However, researchers involved in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial were quick to assert that the controversial drug Avandia […]

A diabetes drug trial was halted recently after it was determined that trial participants receiving aggressive diabetes treatment were dying at a higher rate than those who did not receive intensive therapy.  However, researchers involved in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial were quick to assert that the controversial drug <"https://www.yourlawyer.com/practice_areas/defective_drugs">Avandia was not to blame for the deaths, and that the overly aggressive treatment administered to some participants was most likely the cause of the deaths.

The ACCORD trial, sponsored by the U.S. National Heart, Lung, and Blood Institute (NHLBI), began in 2001 at 77 sites in the United States and Canada with the enrollment of 10,251 patients with type 2 diabetes who were at high risk for heart attack or stroke because they had at least two risk factors, including high blood pressure, high cholesterol or obesity. Those in the trial received either medications to aggressively lower their blood sugar below recommended levels, or standard treatment to control their disease.  The goal of the aggressive treatment group was to lower blood sugar levels — a measure known as hemoglobin A1c — to below 6 percent, far below the current target of under 7 percent and closer to what is seen in non-diabetics. The researchers said they would now adjust the ACCORD trial so the blood sugar of patients would not be lowered so much.

Yesterday, it was announced that 257 people who received the intensive therapy had died, compared with 203 in patients in a standard treatment group.  Among the 257 deaths in the aggressive therapy group, 50 percent were due to heart attacks or other cardiovascular causes.  Patients in the intensive treatment group had fewer nonfatal heart problems, but they had more unexpected sudden deaths, even without a clear heart attack. While they could not pinpoint the reason for the heightened risk, they all but ruled out any of the diabetes drugs – including Avandia – that were used.

“Because of the recent concerns raised with regard to rosiglitazone, we specifically analyzed the data to try and determine whether there was any link between this particular medication and the increased deaths we were seeing in the ACCORD intensive treatment group,” Dr. William Friedewald, chairman of the ACCORD Steering Committee. “At this time, we have found no link, and thus the use of rosiglitazone does not seem to explain the increased mortality.”

Avandia has been a subject of controversy since May 2007, when an analysis of 42 clinical trails published by the Cleveland Clinic showed that patients taking the drug had a 43-percent higher risk of having a heart attack.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I want to start off with saying thank you to the entire firm for taking my case but I especially want to thank Benita Rollis. She kept me updated throughout this whole process that was completely new to me and always answered any concerns I had. Parker Waichman LLP you have a gem in Benita Rollis and I will definitely recommend your law firm. Thank you.
C Torres
3 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness I’m very please with the service that I received from P/W , very professional and efficient with good knowledge of the service that they offer.
Anthony Gordon
2 years ago
5 Star Reviews 150
I highly recommend this law firm for their excellent work on my case. Tina went above and beyond to ensure a successful outcome. Her dedication and hard work were evident throughout the entire process. She was always available to answer my questions and provided clear communication every step of the way. The firm as a whole was professional, knowledgeable, and provided exceptional service. I am grateful for their expertise and highly recommend them to anyone in need of legal assistance.
Danny Mulholland
9 months ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038